EP-1689: Which technique is dosimetrically superior in the treatment of breastcancer: VMAT or Fixed Field IMRT  by Murphy, S. & Drury-Smith, H.
S788                                                                                                                                                  ESTRO 35 2016 
_____________________________________________________________________________________________________ 
guarantee a better sparing of normal tissue. Obtained index 
are aligned with reported results in analogous studies with 
Tomotherapy. Gammaknife perfexion seems to be the 
technique able to guarantee better results in term of CI. 
OARs sparing in case of no co-planar beam delivered by LINAC 
exhibit worse performance than modulated technique.  
 
Conclusion: Treatment of brain metastasis with Tomotherapy 
showed encouraging results in term of dosimetric outcome. 
Lesion size and prescription strategies showed a statistically 
significant influence on dosimetric distribution. Clinical 
outcome with frameless immobilization has proven feasible, 
well tolerated and able to increase patient compliance as 
exclusive treatment of brain oligo-MTS. 
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Purpose or Objective: It is challenging to achieve 
homogeneous target dose distribution in intensity-modulated 
radiotherapy (IMRT) for sinonasal cancer (SNC). To overcome 
this difficulty, we proposed a base-dose-compensation (BDC) 
planning technique, in which the treatment plan is further 
optimized based on the original plan with half of the 
prescribed number of fractions and finally the number of 
fractions of treatment plan was restored from a half to the 
total. 
 
Material and Methods: CT scan data of 13 patients were 
included. Generally acceptable original IMRT plans were 
created and further optimized individually by (1) the BDC 
technique and (2) a local-dose-control (LDC) planning 
technique, in which the original plan is further optimized by 
addressing hot and cold spots. We compared the target dose 
coverage, organ-at-risk (OAR) sparing, total planning time 
and monitor units (MUs) among the original, BDC, LDC IMRT 
plans and additionally generated volumetric modulated arc 
therapy (VMAT) plans. 
 
Results: The BDC technique provided significantly superior 
dose homogeneity/conformity by 23%-48%/6%-9% compared 
with both the original and LDC IMRT plans, as well as reduced 
doses to the OARs by up to 18%, with acceptable MU 
numbers. Compared with VMAT, BDC IMRT yielded superior 
homogeneity, inferior conformity and comparable overall 
OAR sparing. The planning of BDC, LDC IMRT and VMAT 
required 30, 59 and 58 minutes on average, respectively. 
 
Conclusion: The BDC planning technique can achieve 
significantly better dose distribution with shorter planning 
time in the IMRT for SNC. 
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Purpose or Objective: Recently Automatic Brain Metastasis 
Planning (ABMP) Element [BrainLAB] was commercially 
released by BrainLAB. It covers multiple off-isocenter targets 
at a time inside a multi-leaf collimator field and enables 
stereotactic radiosurgery (SRS) / stereotactic radiotherapy 
(SRT) with a single group of lineac-based dynamic conformal 
multi-arc for multiple brain metastases. In this study, dose 
planning of ABMP (ABMP-single isocenter dynamic conformal 
arc [ABMP-SIDCA]) for stereotactic radiosurgery of small 
multiple brain metastasis was evaluated in comparison with 
those of conventional multi-isocenter DCA (iPlan [BrainLAB]-
MIDCA) and Gamma Knife [Elekta] SRS (GKRS).  
 
Material and Methods: Simulation planning was performed 
with ABMP-SIDCA and GKRS was made in a case of multiple 
small brain metastasis (9 tumors of 0.2 to 0.7 ml in volume) 
which were originally treated with iPlan-MIDCA. First, 
dosimetric comparison was done between ABMP-SIDCA and 
iPan-MIDCA in the setting with PTV (planned target volume) 
margin of 2mm and D95=95% dose (19 Gy). Second, dosimetry 
of GKRS was compared with that of ABMP-SIDCA with PTV 
margin of 0, 1mm, and 2mm, and D95=100% dose (20 Gy). 
 
Results: First, CI (1/Paddick’s CI) and GI (V[half of 
prescription dose] / V[prescription dose]) in ABMP-SIDCA 
(mean, 1.36 and 5,12) were compatible with those of iPlan-
MIDCA (mean, 1.53 and 4.84). Second, PIV (prescription 
isodose volume) of GKRS (mean, 0.23 ml) was between that 
of no margin- and 1mm-margin ABMP-SIDCA (mean, 0.10 ml 
and 0.28 ml). Considering dose gradient, the same tendency 
was observed. The mean of V[half of prescription dose] of 
GKRS, no margin-, and 1 mm margin-ABMP-SIDCA were 0.87 
ml, 0.60 ml, and 1.37 ml respectively.  
 
Conclusion: The conformity and dose gradient with ABMP-
SIDCA was as good as those of conventional MIDCA by each 
lesion. If the conditions permit minimal PTV margin (1mm or 
less), ABMP-SIDCA might provide excellent dose fall-off 
compatible with GKRS and enable a short treatment time.  
The author has no COI. However this study was performed by 
use trial of ABMP Elements provided by BrainLAB (Tokyo). 
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Purpose or Objective: To determine in terms of target 
coverage and organ at risk (OAR) doses which concomitant 
boost technique is superior in the treatment of breast 
cancer; VMAT or fixed field IMRT. 
 
Material and Methods: 30 previously treated breast patients 
(15 Left, 15 Right) were re-planned with both VMAT and fixed 
field concomitant IMRT techniques. A two dose prescription 
was used similar to previous planning studies (1-3) using the 
same dose constraints as per the IMPORT HIGH trial (1). 40Gy 
in 15 fractions was planned to the whole breast while 
boosting the tumour bed to 48Gy in 15 fractions. A base plan 
consisting of the existing forward planned tangent fields 
delivered approximately 38Gy to the whole breast while the 
tumour bed was boosted with approximately 10Gy using an 
inverse planned IMRT option. A single partial arc starting and 
finishing at the tangent angles formed the VMAT portion and 
the ff-IMRT trial used the 2 existing tangent beam angles 
followed by 3 further equally spaced beams. Target 
coverage, heart, ipsilateral lung, contralateral lung and 
contralateral breast dose was measured. A Two-tailed t-Test 
sample for means was used to compare the dosimetric 
differences between the techniques using excel software. 
Statistical significance was defined as P<0.05. 
 
Results: Maximum dose D2% was statistically lower for VMAT; 
103.2% vs. 103.7% for ff IMRT whereas minimum doses were 
equivalent. No differences were found with ipsilateral lung 
mean and V5Gy doses, contralateral breast mean dose, heart 
mean dose, heart V5Gy and V10Gy doses. VMAT demonstrated 
statistically lower V2Gy doses to the contralateral lung (0.7% 
vs.1.6%) and heart for both left (19.0%/22.6%), and right 
(5.5%/8.8%) sided patients respectively. Whereas ff-IMRT 
boasted significantly lower ipsilateral lung V20Gy, V18Gy and 
V10Gy doses (7.9/8.6/13.1 vs. 8.1/8.8/13.4%) with VMAT 
respectively 
 
Conclusion: Despite both VMAT and ff-IMRT plans reaching 
statistical significance in a number of OAR and target 
parameters there is no clear superior option and whether the 
differences are clinically significant is a different question. 
Both techniques met all mandatory dose constraints and the 
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majority of cases surpassed all optimal dose constraints 
demonstrating the high quality of the planning technique. 
The incorporation of deep inspiration breath hold (DIBH) 
ensured doses to the heart were exceptionally low; mean 
heart dose for left breast cases averaged 1.4Gy for both 
treatment options. As neither technique has proven superior, 
the significantly reduced treatment times associated with 
VMAT make this a more desirable option to implement 
clinically. 
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Purpose or Objective: To evaluate the SharePlan software in 
conversion of helical tomotherapy (HT) to a step and shoot 
IMRT (sIMRT) for patients with high-risk prostate cancer and 
hip prosthesis. 
 
Material and Methods: Analysis was performed for 16 
consecutive patients treated on HT.  
The HT plans were converted to sIMRT plans. 3DCRT, sliding 
window IMRT (dIMRT) and VMAT plans for a c-arm linear 
accelerator (CLA) were created manually.  
The doses in planning target volume (PTV), bladder, rectum, 
bowels, femoral heads and hip prosthesis were compared 
using: (i) a qualitative analysis of doses in averaged dose-
volume histograms, (ii) a quantitative, ranking procedure 
performed for each patient separately, and (iii) statistical 
testing based on the Friedman ANOVA and Nemenyi method. 
 
Results: For the bladder, rectum, and femoral head, the best 
dose distributions were observed for HT and sIMRT and then 
for dIMRT, VMAT, and finally for 3DCRT (p-values were, 
respectively, 0.002, 0.004 and p=0.024). For the bowels, 
3DCRT was significantly different from the rest of the 
techniques (p=0.009). For the hip prosthesis, the differences 
were only between 3DCRT and HT/sIMRT (p=0.038). 
The first part of Table 1 shows mean doses and standard 
deviations computed from the average dose-volume 
histograms for planning target volume, hip prosthesis and 
organs at risk. The values presented in per cent and 
normalised up to the prescribed dose (46 Gy). The second 
part of Table 1 shows the statistical testing of the differences 
between dose distributions in these structures. The results of 
the Friedman ANOVA testing noted as the p-value. Results of 
the Nemenyi analysis presented as the groups (A, B, C). 
Statistical testing performed on the 0.05 significance level. 
 
 
 
Despite the greater scoring in the ranking procedure, 
HT/sIMRT did not differ statistically from dIMRT/VMAT. The 
scores were, respectively, 75% and 72% to 61% and 64%. 
Figure 1 shows the ranking procedure for the dose 
distributions obtained in the planning target volume, hip 
prosthesis and organs at risk for: helical tomotherapy (HT, 
brown bars), plans converted on the SharePlan station 
(sIMRT, blue bars) and plans prepared manually for C-arm 
linear accelerators (3DCRT - red bars, dIMRT - green bars and 
VMAT - purple bars). 
 
 
Conclusion: The SharePlan is an efficient tool for the 
conversion of HT plans for patients with prostate cancer and 
hip prosthesis. Dose distributions in sIMRT and in HT plans are 
similar and are generally better than in CLA plans. 
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Purpose or Objective: Several reports support the potential 
benefits of proton therapy (PT) when compared to photon 
techniques in craniospinal irradiation (CSI) to reduce late 
toxicity and risk of secondary malignancies. PT is increasingly 
regarded as the gold standard for CSI, particularly in 
pediatric patients. Nevertheless, lens sparing with good 
coverage of the cribriform plate remains a challenge, 
especially in very young patients, as the lens dose increases 
significantly with decreasing age (Cochran et al, Int JRadiat 
Oncol Biol Phys 2008;70:1336-42). The technique and the 
beam arrangement used at our center for lens sparing in the 
treatment of the whole brain for our first 6 y.o. male 
patient, is described and compared with data reported in 
other studies. 
 
Material and Methods: CSI is delivered by active scanning PT 
with three isocenters, using three cranial beams plus two 
additional postero-anterior spinal beams. Cranial and caudal 
field junctions are planned by the ancillary-beam technique 
(Farace et al, Acta Oncol 2015; 54:1075-8). The three-beams 
arrangement for brain irradiation includes two lateral 
opposed beams (gantry angle 90° and 270°), with couch 
angle ±15° to minimize the overlap between the cribriform 
plate and the lens, and an additional posterior beam. Single-
field-optimization of the three equally-weighted beams is 
performed. A total dose of 36 Gy in 20 fractions is prescribed 
following international radiation guidelines for high risk 
medulloblastoma. During optimization, coverage of the 
cribriform plate is assumed as the priority goal and lens 
sparing as a secondary objective. Our technique is compared 
with two more conventional approaches: i) two opposed-
lateral beams and ii) two angled (±20°) posterior-oblique 
beams. 
 
Results: In figure A and B the dose distribution obtained by 
the lens-sparing technique on two slices at the level of the 
cribriform plate and of the lenses are shown. The coverage of 
the cribriform plate is similar in all beam arrangements. In 
Figure C, the dose volume histogram for the three beams’ 
arrangement is shown. Adequate target coverage is obtained 
by all beam arrangements. In addition, the lens-sparing 
technique allowed to markedly decrease the dose to the 
